Smoking and prostate cancer survival and recurrence

JAMA

Volumn 305, Issue 24, 2011, Pages 2548-2555

  Kenfield, Stacey A ^a   Stampfer, Meir J ^a   Chan, June M ^b   Giovannucci, Edward ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; SMOKING CESSATION; SURVIVAL RATE;

EID: 79959392796     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.879     Document Type: Article

References (42)

1. US Department of Health and Human Services. The Health Consequences of Smoking. A Report of the Surgeon General. Washington, DC: US Dept of Health and Human Services; 2004.
2. Zu K, Giovannucci E. Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control. 2009;20(10):1799-1810.
3. Daniell HW. A worse prognosis for smokers with prostate cancer. J Urol. 1995;154(1):153-157.
4. Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP. Smoking history and cancer patient survival. Cancer Detect Prev. 1997;21(6):497-509.
5. Pickles T, Liu M, Berthelet E, et al; Prostate Cohort Outcomes Initiative. The effect of smoking on outcome following external radiation for localized prostate cancer. J Urol. 2004;171(4):1543-1546.
6. Moreira DM, Antonelli JA, Presti JC Jr, et al. Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy. Urology. 2010;76(5):1218-1223.
7. Joshu CE, Mondul AM, Meinhold CL, et al. Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst. 2011;103(10):835-838.
8. Pantarotto J, Malone S, Dahrouge S, Gallant V, Eapen L. Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. BJU Int. 2007;99(3):564-569.
9. Oefelein MG, Resnick MI. Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer. J Urol. 2004;171(6, pt 1):2281-2284.
10. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes Control. 2008;19(1):25-31.
11. Jäger T, Eisenhardt A, Rübben H, Lümmen G. Does cigarette smoking influence the survival of patients with prostate cancer? Urologe A. 2007;46(4):397-400.
12. Giovannucci E, Rimm EB, Ascherio A, et al. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prev. 1999;8(4, pt 1):277-282.
13. Kupelian PA, Elshaikh M, Reddy CA, Zippe C, Klein EA. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era. J Clin Oncol. 2002;20(16):3376-3385.
14. Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Urology. 2003;61(2):365-369.
15. Roach M III, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65(4):965-974.
16. Kuban DA, Levy LB, Potters L, et al. Comparison of biochemical failure definitions for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006;65(5):1487-1493.
17. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140(11):1016- 1019.
18. Wilson KM, Kasperzyk JL, Rider JR, et al. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study [published online ahead of print May 17, 2011]. J Natl Cancer Inst. doi: 10.1093/jnci/djr151.
19. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the Health Professionals Follow-up Study. Int J Cancer. 2007;121(7):1571-1578.
20. Chan JM, Holick CN, Leitzmann MF, et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control. 2006;17(2):199-208.
21. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alphatocopherol and beta-carotene. J Natl Cancer Inst. 1998;90(6):440-446.
22. Chan JM, Stampfer MJ, Ma J, et al. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev. 1999;8(10):893-899.
23. Ma J, Li H, Giovannucci E, et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer. Lancet Oncol. 2008;9(11):1039-1047.
24. Byrne MM, Davila EP, Zhao W, et al. Cancer screening behaviors among smokers and nonsmokers. Cancer Epidemiol. 2010;34(5):611-617.
25. Merrick GS, Butler WM, Wallner KE, et al. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;58(4):1056-1062.
26. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391(6):603-613.
27. Pour PM. Prostatic cancer induced in MRC rats by N-nitrosobis(2- oxopropyl)-amine and N-nitrosobis(2-hydroxypropyl)amine. Carcinogenesis. 1983;4(1):49-55.
28. Waalkes MP, Rehm S. Cadmium and prostate cancer. J Toxicol Environ Health. 1994;43(3):251-269.
29. Achanzar WE, Diwan BA, Liu J, et al. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res. 2001;61(2):455-458.
30. Zeng X, Jin T, Jiang X, Kong Q, Ye T, Nordberg GF. Effects on the prostate of environmental cadmium exposure. Biometals. 2004;17(5):559-565.
31. Vinceti M, Venturelli M, Sighinolfi C, et al. Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ. 2007;373(1):77-81.
32. Benbrahim-Tallaa L, Liu J, Webber MM, Waalkes MP. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells. Prostate. 2007;67(2):135-145.
33. Nock NL, Liu X, Cicek MS, et al. Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15(4):756-761.
34. Handa K, Ishii H, Kono S, et al. Behavioral correlates of plasma sex hormones and their relationships with plasma lipids and lipoproteins in Japanese men. Atherosclerosis. 1997;130(1-2):37-44.
35. Tamimi R, Mucci LA, Spanos E, et al. Testosterone and oestradiol in relation to tobacco smoking, body mass index, energy consumption and nutrient intake among adult men. Eur J Cancer Prev. 2001;10(3):275-280.
36. Allen NE, Appleby PN, Davey GK, Key TJ. Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control. 2002;13(4):353-363.
37. Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men: the fifth Tromsø study. Int J Androl. 2007;30(3):137-143.
38. Shiels MS, Rohrmann S, Menke A, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control. 2009;20(6):877-886.
39. Enokida A, Shiina H, Urakami S, et al. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer. 2006;106(1):79-86.
40. Villablanca AC. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol. 1998;84(6):2089-2098.
41. Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7(7):833-839.
42. Jain RK. Clearing the smoke on nicotine and angiogenesis. Nat Med. 2001;7(7):775-777.